Qatar Airways Cargo move 30million vaccine across destinations

Post By : Karvi Rana
Post Date : May 27, 2022
Share with
Reading Time: 2 minutes

Qatar Airways Cargo has transported almost 30million COVID-19 vaccines to destinations across its network, including Africa, the Middle East, the Americas, Europe, and Asia.

The Middle East carrier expects to move further consignments after the COVID-19 vaccine export restriction was lifted by the Indian Government late last year.In January 2014, when Qatar Airways Cargo launched its pharma product, India was amongst the first markets to offer it.

The world’s third largest in terms of volume, the Indian pharmaceuticals market caters to around 60% of global vaccine demand.The airline has since grown to become one of the Indian subcontinent’s leading cargo carriers.

Today, with a pharmaceuticals market share of almost 18% in India, almost every fifth pharma shipment leaves the country on a Qatar Airways Cargo aircraft.

“The Indian pharma market is very important for Qatar Airways Cargo. We work closely with major vaccine manufacturers in India through our global partnerships with international as well as leading local freight forwarders,”

Ehab Matta, senior manager of the regional cargo Indian subcontinent, Middle East & Pakistan – Qatar Airways.

Hyderabad was the first station in the Qatar Airways Cargo network to deploy Envirotainer’s new Releye RLP containers as soon as they had been approved for carriage on Qatar Airways aircraft due to close collaboration with customers. Hyderabad also holds the national record for the most active pharma containers on one flight, having moved 11 ULDs.

Home to over 2,500 of the country’s 3,000 pharma companies and 10,500 manufacturing units, Hyderabad is India’s main pharma export station. Mumbai, Ahmedabad, Delhi, Bengaluru, and Chennai also play important roles given the widespread pharma production facilities across India.

“India produces and exports both conventional vaccines as well as COVID-19 vaccines,” said Matta, adding: “Ten COVID-19 vaccines are approved for use in India, whilst Indian manufactured vaccines are approved in over 138 countries globally.“

We have moved close to 30m COVID-19 vaccines to date to several destinations across our network including Africa, the Middle East, Americas, Europe, and Asia. We expect to move more since the COVID-19 vaccine export restriction was lifted by the Indian Government late last year.“Our participation in the UNHCR vaccine program, through Kuehne and Nagel, is a good testimony to our commitment.”

The increasing involvement of both India and Qatar Airways Cargo in supporting healthcare with charters and transporting all kinds of aid, relief material, and vaccines, led to the airline recruiting Sunita Sanghvi as regional cargo sales manager – Products.Sanghvi, who joined the airline in Mumbai in March this year, is responsible for its pharma product development across India and the rest of the subcontinent.

He will work closely with the regional sales teams, customers, and partners, to provide dedicated focus, and enhanced and tailor-made solutions in the face of increasing pharma demand.

Matta stated: “Having said that, most of our teams across all Indian stations are trained in our pharma product and are well versed with commercial and operational requirements as well as specific customer needs.“It could be said that our largest pool of pharma experts is based in India,” while pointing out that the Indian teams are supported by the central product management team based at the Doha head office.

Leave a Reply

Your email address will not be published.